Key result
Angiopoietin-2 levels >4101 pg/mL linked to ~640% higher ICU admission risk in acute PE.
Why the study?
Risk stratification of acute PE is important to identify patients at risk for hemodynamic collapse who would benefit from more aggressive therapies, prompting evaluation of Ang-2 as a signaling molecule upregulated in tissue hypoxia.
Does Angiopoietin-2 level correlate with disease severity, right ventricular dysfunction, and need for ICU admission in patients with acute pulmonary embolism?
Observational (n=65)
No
Does Angiopoietin-2 level correlate with disease severity, right ventricular dysfunction, and need for ICU admission in patients with acute pulmonary embolism?
Elevated Angiopoietin-2 levels (> 4101 pg/mL) may serve as a novel biomarker for risk stratification in acute pulmonary embolism, predicting RV dysfunction and the need for ICU admission.
Answers are grounded in this paper and cite their sources.
May inform early risk stratification in acute PE; hypothesis-generating and requires prospective validation before clinical use.
Risk stratification of acute pulmonary embolism (PE) is important to identify patients at risk for hemodynamic collapse who would benefit from more aggressive therapies. Angiopoietin-2 (Ang-2) is a signaling molecule involved in angiogenesis and is upregulated in response to tissue hypoxia. We aimed to assess the association of Ang-2 with (1) PE severity, (2) echocardiographic and invasive hemodynamic markers of right ventricular (RV) dysfunction, and (3) need for intensive treatment. Patients presenting to our institution with acute PE were included in a prospective database and blood samples were collected and stored for later analysis. A total of 65 patients were included in the study. Ang-2 correlated with PE risk stratification and echocardiographic and invasive hemodynamic markers of RV dysfunction and pulmonary hypertension. An Ang-2 level of > 4101 pg/mL had an odds ratio of 7.4 (95% CI: 1.53–12.5, p < 0.01) for intensive care unit (ICU) admission. In conclusion, Ang-2 correlates with PE severity, RV dysfunction, and need for ICU admission. Ang-2 holds promise as a novel marker that can aid in risk stratification for this patient population.
No takes yet. Share an insight, caveat, or question.
Newman et al. (2021) conducted an observational in Acute pulmonary embolism (PE) (n=65). Angiopoietin-2 (Ang-2) level > 4101 pg/mL vs. Ang-2 level ≤ 4101 pg/mL was evaluated on Intensive care unit (ICU) admission (OR 7.4, 95% CI 1.53-12.5, p=< 0.01). An Angiopoietin-2 level > 4101 pg/mL was associated with increased risk of intensive care unit admission in patients with acute pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: